Campbell & CO Investment Adviser LLC Immunocore Holdings PLC Transaction History

Campbell & CO Investment Adviser LLC

  • $1.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$60.14 - $75.36 $440,345 - $551,785
7,322 New
7,322 $475,000
Q3 2023

Nov 08, 2023
SELL
$49.5 - $66.6 $33,412 - $44,954
-675 Reduced 7.81%
7,965 $413,000
Q2 2023

Aug 11, 2023
BUY
$48.54 - $61.64 $419,385 - $532,569
8,640 New
8,640 $518,000

Others Institutions Holding IMCR

# of Institutions
141
Shares Held
41.4M
Call Options Held
197K
Put Options Held
451K
View Full List

About Immunocore Holdings plc

IMCR Quotes by TradingView
  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.24B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email